The Krascendo 1 study showed improved survival rates of 18 months compared to 12 months with current standard of care ...

MAD World Summit 2026 has secured official accreditation from The CPD Group, strengthening its position as a must-attend ...

AbbVie has announced results from the ongoing phase 3 Viti-Up-1 and Viti-Up-2 studies of Rinvoq (upadacitinib; 15mg once ...

In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they ...

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...

Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...

Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms ...

Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in trial enrollment and operations. Agility and flexibility have always been ...

Beam Therapeutics has appointed Eric Foster as Chief Commercial Officer (CCO). Foster will lead Beam’s commercial organisation and strategy as the company advances multiple product candidates across ...

Healthcare has always been complex, but the pace of change feels greater than ever. Innovation is accelerating, AI is transforming how we work and healthcare delivery continues to evolve. In the UK ...

As artificial intelligence continues to transform our industry, it is a question many of us are asking. Yet while the tools at our disposal are evolving rapidly, the qualities that define the best ...